This site is intended for UK healthcare professionals
The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)
This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd.
Information intended for UK healthcare professionals only.
UK/MKT/RZM/20-0029c
Date of preparation: September 2020
Content for healthcare professionals
Access to this content is restricted to UK-based doctors, nurses, and pharmacists
If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one.